Intra-Cellular Therapies Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2017 - 2021
Period Ending	Aug '25 Aug 1, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2017 - 2021
Market Capitalization	952,677	1,047,518	1,145,276	1,107,740	2,604,515	999,067	Upgrade
Market Cap Growth	-4.79%	-8.54%	3.39%	-57.47%	160.70%	380.51%	Upgrade
Enterprise Value	1,310,815	1,372,772	1,484,456	1,431,820	2,887,688	1,230,759	Upgrade
PE Ratio	39.47	98.83	100.70	89.59	266.23	100.68	Upgrade
PS Ratio	3.78	4.41	6.90	8.33	23.14	10.07	Upgrade
PB Ratio	4.14	4.55	8.36	8.60	23.66	9.97	Upgrade
P/FCF Ratio	-	-	188.34	-	-	-	Upgrade
P/OCF Ratio	-	12.05	18.97	29.33	63.58	26.40	Upgrade
EV/Sales Ratio	5.20	5.78	8.94	10.77	25.65	12.40	Upgrade
EV/EBITDA Ratio	15.33	16.37	24.21	30.65	69.16	31.35	Upgrade
EV/EBIT Ratio	19.71	20.96	33.54	45.86	103.21	46.70	Upgrade
EV/FCF Ratio	-	-	244.12	-	-	-	Upgrade
Debt / Equity Ratio	1.75	1.75	2.71	2.66	2.72	2.70	Upgrade
Debt / EBITDA Ratio	4.71	4.79	6.02	7.29	7.11	6.85	Upgrade
Debt / FCF Ratio	-	-	60.99	-	-	-	Upgrade
Quick Ratio	-	1.06	0.77	0.74	0.58	0.43	Upgrade
Current Ratio	-	1.37	1.01	0.99	0.77	0.71	Upgrade
Asset Turnover	-	0.36	0.30	0.26	0.25	0.24	Upgrade
Return on Equity (ROE)	-	5.02%	9.00%	10.72%	11.75%	13.17%	Upgrade
Return on Assets (ROA)	-	6.18%	4.92%	3.85%	3.86%	3.97%	Upgrade
Return on Capital (ROIC)	7.29%	7.17%	5.65%	4.43%	4.48%	4.64%	Upgrade
Return on Capital Employed (ROCE)	-	10.20%	8.70%	6.70%	6.70%	7.20%	Upgrade
Earnings Yield	2.52%	1.01%	0.99%	1.13%	0.46%	1.23%	Upgrade
Earnings Yield	2.52%	1.01%	0.99%	1.13%	0.46%	1.23%	Upgrade
FCF Yield	-	-0.65%	0.53%	-0.83%	-0.04%	-0.17%	Upgrade
Payout Ratio	-	-	7.54%	-	-	0.11%	Upgrade
Buyback Yield / Dilution	-6.93%	-5.01%	-0.16%	-1.27%	-	-	Upgrade

Updated Jan 23, 2025. Source: S&P Global Market Intelligence. Utility template. Financial Sources.